Codexis (CDXS) Interest & Investment Income (2010 - 2026)
Codexis (CDXS) recorded quarterly Interest & Investment Income of $665000.0 in Q1 2026, up 1.37% quarter-over-quarter from $656000.0 in Q4 2025, and down 11.45% on a YoY basis from $751000.0 in Q1 2025.
Codexis (CDXS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Codexis' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $665000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 11.45% year-over-year to $665000.0; the TTM figure through Mar 2026 stood at $2.5 million (down 27.71% YoY), while the FY2025 annual figure was $2.6 million, down 28.47% from the prior year.
- Interest & Investment Income was $665000.0 for Q1 2026 at Codexis, up from $656000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q2 2023 to a low of $42000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $739588.2 across 5 years, with a median of $823000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income plunged 76.27% in 2022, then soared 2492.86% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $823000.0 in 2022, then gained by 10.09% to $906000.0 in 2023, then climbed by 3.75% to $940000.0 in 2024, then sank by 30.21% to $656000.0 in 2025, then advanced by 1.37% to $665000.0 in 2026.
- The last three Interest & Investment Income figures came in at $665000.0 (Q1 2026), $656000.0 (Q4 2025), and $634000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 665,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 665,000.00 |
| Dec 31, 2025 | 656,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 751,000.00 |
| Dec 31, 2024 | 940,000.00 |
| Sep 30, 2024 | 849,000.00 |
| Jun 30, 2024 | 972,000.00 |
| Mar 31, 2024 | 909,000.00 |
| Dec 31, 2023 | 906,000.00 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 823,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 140,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 206,000.00 |